Midaortic syndrome with IgA nephropathy in a child: a case report

Anna Shen, Li Shen, Wenyan Li, Huaiqing Cai, Weihua Zheng, Wenyan Huang, Rufang Zhang, Yulin KangFrontiers in Medicine 2025 · DOI

Abstract

Midaortic syndrome (MAS) is a rare clinical condition characterized by segmental narrowing of the descending thoracic or abdominal aorta. While MAS is a known cause of severe secondary hypertension, its association with IgA nephropathy (IgAN) in pediatric patients has not been previously documented. This case report explores the potential role of MAS-induced chronic ischemia and hypoxia as aggravating factors or even primary drivers in the development of secondary IgAN.

Introduction

IgA nephropathy (IgAN) stands as the most prevalent primary glomerulonephritis globally, particularly among children. It is defined by the deposition of IgA-dominant immune complexes within the glomerular mesangium. While many cases are idiopathic (primary), IgAN can also manifest secondary to systemic conditions such as chronic liver disease, inflammatory bowel disease, or certain infections.

Midaortic syndrome (MAS) involves significant narrowing of the distal thoracic or proximal abdominal aorta, often involving the renal and visceral branches. This leads to severe hypertension and potentially life-threatening organ ischemia. This report details the first known pediatric case where MAS and IgAN co-existed, suggesting a novel mechanistic link between mechanical vascular obstruction and immune-mediated renal damage.

Case Presentation and Diagnostic Journey

A 12-year-old patient presented with severe hypertension. Clinical examination revealed a significant blood pressure discrepancy: 175/125 mmHg in the upper extremities versus 102/69 mmHg in the lower extremities.

Imaging and Vascular Assessment

Abdominal Computed Tomography Angiography (CTA) was performed to investigate the cause of the hypertension and the pressure gradient. The imaging revealed a marked narrowing of the descending aorta, confirming a diagnosis of Midaortic Syndrome.

CTA imaging (A-F) showing aortic narrowing and surgical correction (G-H).

Renal Pathology

To address the patient's heavy proteinuria (12.88 g/24h) and hematuria, a renal biopsy was conducted. Light microscopy and immunofluorescence staining confirmed the diagnosis of IgA nephropathy. The biopsy showed mesangial hypercellularity and significant deposition of IgA, IgM, and complement components C3 and C1q.

Renal biopsy findings showing immunofluorescence (A-D) and histology (E-F) confirming IgAN.

Therapeutic Intervention

The treatment strategy was two-pronged, addressing both the mechanical vascular issue and the inflammatory renal disease:

  1. Surgical Correction: A bypass was established using a GORE-TEX Vascular Graft to circumvent the aortic stenosis, restoring normal blood flow to the lower body and kidneys.
  2. Medical Management: The patient received a regimen of immunosuppressants, including methylprednisolone and cyclophosphamide, alongside antihypertensive medications.

The authors propose that MAS may act as a catalyst for IgAN through several pathways, aligned with the established "Four-Hit Hypothesis" of IgAN development:

  • The Gut-Kidney Axis: Ischemia in the mesenteric arteries due to MAS can impair the intestinal mucosal barrier. This dysfunction may trigger the production of galactose-deficient IgA1 (Gd-IgA1), the critical "first hit" in IgAN.
  • Reduced Hepatic Clearance: Impaired blood flow to the liver may reduce the clearance of circulating IgA immune complexes, facilitating their deposition in the glomerular mesangium.
  • Hypoxia-Induced Inflammation: Chronic renal ischemia leads to the upregulation of Hypoxia-Inducible Factor-1α (HIF-1α) and Kidney Injury Molecule-1 (KIM-1). These factors are known to promote renal inflammation and fibrosis, potentially accelerating the progression of IgAN.

Clinical Outcomes

The patient showed remarkable improvement following the combined surgical and medical intervention:

  • Blood Pressure: Stabilized to approximately 125/65 mmHg.
  • Proteinuria: Decreased significantly from 12.88 g/24h to 1.75 g/24h at the two-year follow-up.
  • Renal Function: The estimated glomerular filtration rate (eGFR) improved from 67.0 to 160.0 mL/min/1.73 m², indicating a return to normal range.

Conclusion

This case highlights MAS as a potential aggravating factor and a possible new cause of secondary IgAN in children. The significant clinical improvement observed only after surgical correction of the aorta suggests that the vascular narrowing was a primary driver of the renal pathology. Clinicians should consider vascular screening in pediatric patients with IgAN and refractory hypertension. Further research into the role of chronic hypoxia in immune-mediated kidney diseases is warranted.

Summary updated

Abstract

MAS is an aggravating factor and might be a new cause of secondary IgAN.
BibTeX
@inproceedings{shen2025midaortic,
  author = {Anna Shen and Li Shen and Wenyan Li and Huaiqing Cai and Weihua Zheng and Wenyan Huang and Rufang Zhang and Yulin Kang},
  title = {{Midaortic syndrome with IgA nephropathy in a child: a case report}},
  booktitle = {Frontiers in Medicine},
  year = {2025},
  doi = {10.3389/fmed.2025.1567332},
}
Figure